{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:38:17Z","timestamp":1772221097578,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jaapos.2013.11.014","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T04:45:18Z","timestamp":1396241118000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis"],"prefix":"10.1016","volume":"18","author":[{"given":"Monica L.","family":"Bratton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Guang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Weakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2013.11.014_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2005.01.044","article-title":"Analysis of pediatric uveitis cases at a tertiary referral center","volume":"112","author":"Kump","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2013.11.014_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2013.11.014_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/ocii.8.4.251.6459","article-title":"Uveitis in children","volume":"8","author":"Cunningham","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaapos.2013.11.014_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","article-title":"Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.11.014_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/jop.2008.0087","article-title":"Complications and safety profile of posterior subtenon injection of triamcinolone acetonide","volume":"25","author":"Byun","year":"2009","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.jaapos.2013.11.014_bib6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajo.2004.05.028","article-title":"Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection","volume":"138","author":"Inoue","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.11.014_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09273940500545684","article-title":"The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema","volume":"14","author":"van Kooij","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaapos.2013.11.014_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2013.11.014_bib9","first-page":"1613","article-title":"Dexamethasone intravitreal implant for the\u00a0treatment of noninfectious uveitis","volume":"5","author":"Hunter","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.11.014_bib10","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ophtha.2012.07.025","article-title":"Dexamethasone implant in pediatric uveitis","volume":"119","author":"Taylor","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2013.11.014_bib11","first-page":"632","article-title":"Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis","volume":"17","author":"Cordero-Coma","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2013.11.014_bib12","series-title":"Ozurdex [package insert]","year":"2010"},{"key":"10.1016\/j.jaapos.2013.11.014_bib13","unstructured":"Intraocular inflammation and uveitis. Basic Science Series. Vol. 9. American Academy of Ophthalmology; 2009-2010."},{"key":"10.1016\/j.jaapos.2013.11.014_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.11.014_bib15","series-title":"Retisert [package insert]","year":"2009"},{"key":"10.1016\/j.jaapos.2013.11.014_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/IAE.0b013e31822058bb","article-title":"Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert)","volume":"32","author":"Patel","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2013.11.014_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","article-title":"Biological response modifier therapy for refractory childhood uveitis","volume":"91","author":"Gallagher","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2013.11.014_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2013.11.014_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853114000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853114000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:19:33Z","timestamp":1761077973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853114000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1091853114000615"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2013.11.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718461506.793529307","asserted-by":"object"}]},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2013.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}